GO
Loading...

U.S. Video

Small cap plays for a volatile market     Tue, 28 Oct '14 | 6:37 AM ET

Craig Hodges, Hodges Small Cap Fund, and Chris Retzler, Needham Growth Fund, make the case for buying small cap stocks as market tensions remain high. We think buybacks will provide some support for small caps, says Retzler.

MSG considers spin-off     Tue, 28 Oct '14 | 6:27 AM ET

John Rogers, Jr., Ariel Investments CIO & CEO, discusses Madison Square Garden's exploration of separating its entertainment business from its media and sports business.

Novartis' precision M&A plan: CEO     Tue, 28 Oct '14 | 6:12 AM ET

We are focusing on three big divisions in the next five years - pharmaceuticals, generics and eye care., says Joe Jimenez, Novartis CEO, explaining how Novartis plans to benefit from partnering with other big pharma companies.

Novartis CEO on big pharma pipeline     Tue, 28 Oct '14 | 6:11 AM ET

We are focusing on innovation, says Joe Jimenez, Novartis CEO, discussing the company's growth prospects and the top three drugs driving sales.

Twitter falls after Q4 sales warning     Tue, 28 Oct '14 | 6:07 AM ET

Tony Wible, Janney Capital Markets, provides his take on Twitter's outlook and weighs in on how Twitter makes money and its ability to grow users.

Traders watching oil and earnings     Tue, 28 Oct '14 | 5:48 AM ET

As markets await Fed's move to end the quantitative easing program when it releases its statement Wednesday, traders keep eyes on oil and earnings.

Cramer's long-term Twitter call     Mon, 27 Oct '14 | 7:00 PM ET

Twitter shares traded down after hours, but here's what Mad Money host Jim Cramer thinks happens next.

Cramer: All eyes on oil     Mon, 27 Oct '14 | 6:25 PM ET

Mad Money host Jim Cramer dissects Goldman Sachs' call for lower oil prices and shares his take on the commodity.

17 trades in 67 seconds     Mon, 27 Oct '14 | 5:00 PM ET

How to trade Twitter and Facebook, as well as a look at oil services and Tesla, with the Fast Money traders.

Allergan CEO David Pyott discusses the company's earnings, mergers and acquisitions, and sales growth, with Mad Money's Jim Cramer. Pyott says the recent quarter was the company's best in 64 years.

Cramer: Dazed and confused market     Mon, 27 Oct '14 | 6:00 PM ET

Mad Money host Jim Cramer navigates the way through oil headlines and shares the essential premise of this market.

The Fast Money traders share their final trades of the day.

Dissecting bearish bets on Target, with CNBC contributor Mike Khouw of Dash Financial Group.

Prosensa pops on Sarepta FDA delay     Mon, 27 Oct '14 | 5:46 PM ET

Hans Schikan, Prosensa CEO, discusses its muscular dystrophy drug now under review by the FDA.

The Fast Money traders take a look at today's biggest market movers.

The race to stop Ebola     Mon, 27 Oct '14 | 5:40 PM ET

New CDC guidelines call for travelers from Liberia, Sierra Leone or Guinea to be monitored for 21 days. CNBC's Meg Tirrell provides the latest on Ebola in the U.S.

CNBC's Dominic Chu reports the 5-year old boy in New York City has tested negative for Ebola.

Investors may still be shell-shocked by October's steep selloff, but Goldman Sachs is as bullish as ever, predicting the market could set a new high by year-end.

The FM traders share the best way to play Amgen, Cliffs Natural and Manitowoc.

Young adults are putting down Big Macs in favor of trendier -- and supposedly healthier -- options from other fast-food establishments. Are the golden arches showing signs of aging?

Merck good medicine?     Mon, 27 Oct '14 | 5:05 PM ET

Merck shares fell more than 2 percent Monday after the pharmaceutical giant reported mixed third-quarter earnings results. But could the pullback be a good buying opportunity?

Will cheaper gas prices help Ford sell more cars and trucks?

CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets. Oil fell below $80 today, but did close around $81.

Gartman: Crude the new whale oil     Mon, 27 Oct '14 | 5:11 PM ET

Is a Crude collapse ahead? Dennis Gartman of the Gartman Letter, provides factors contributing to the decline of oil.

Twitter sinks after hours     Mon, 27 Oct '14 | 5:05 PM ET

Robert Peck, SunTrust Robinson Humphrey, provides perspective on Twitter's earnings call and why the stock is falling even after its earnings beat.

Trader still long Twitter     Mon, 27 Oct '14 | 5:00 PM ET

CNBC's Julia Boorstin analyzes Twitter's quarterly numbers. The FM crew trades the name.

Don't like your Tesla? Return it     Mon, 27 Oct '14 | 4:51 PM ET

Tesla is offering a new leasing program where customers could return a leased vehicle in 3 months if not satisfied, reports CNBC's Phil LeBeau.

CNBC.com Managing Editor Allen Wastler reports inequality worrying the wealthy; Steve Ballmer's LA Clippers; and Wal-Mart's category slip-up are the hottest topics on CNBC.com.

$75 oil: Winners & losers     Mon, 27 Oct '14 | 4:37 PM ET

Who is impacted most by falling oil prices, with Stephen Schork of The Schork Report.

Amazon to $100?     Mon, 27 Oct '14 | 4:27 PM ET

Bob Olstein thinks Amazon shares could be headed to $100. Where the stock is headed, with Ari Zoldan, Quantam Networks, and the "Closing Bell" panel.

CNBC TV Worldwide

  • The reality series features the sharks who give budding entrepreneurs the chance to make their dreams come true.

  • “Restaurant Startup” is on a quest to discover, invest in and launch America's next generation of epicurean superstars.

  • CNBC's "American Greed" examines the dark side of the American dream. Some people will do anything for money!